In mice, genetic deletion of GSDMD reduces neutrophil/monocyte recruitment to the infarcted heart, resulting in reduced infarct size, improved cardiac function, and increased survival after MI [65]. The gene discussed is GSDMD; the disease is myocardial infarction.